Recommendations concerning studies on therapeutic equivalence

Drug Information Journal

Volumn 30, Issue 1, 1996, Pages 195-200

  Windeler, Jürgen ^a   Trampisch, Hans Joachim ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

New therapy; Standard therapy; Therapeutic equivalence

Indexed keywords

NEW DRUG;

CLINICAL TRIAL; DRUG CONTRAINDICATION; DRUG COST; DRUG EFFECT; DRUG EFFICACY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; TREATMENT OUTCOME;

EID: 0030059336     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286159603000123     Document Type: Review

References (24)

1. Blackwelder WC. "Proving" the null hypothesis in clinical trials. Control Clin Trials. 1982;3:345-353.
2. Blackwelder WC, Chang MA. Sample size graphs for "proving" the null hypothesis. Control Clin Trials. 1984;5:97-105.
3. Boflnger E. Expanded confidence intervals, onesided tests, and equivalence testing. J Biopharm Stat. 1992;2:181-188.
4. Dunnett CW, Gent M. Significance testing to establish equivalence between treatments with special reference to data in the form of 2 × 2 tables. Biometrics. 1977;33:593-602.
5. Farrington CP, Manning G. Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk. Stat Med. 1990; 9:1447-1454.
6. Huque MF, Dubey S. Design and analysis for therapeutic equivalence clinical trials with a binary clinical endpoint. American Statistical As-sociation 1990. Proceedings of the Biopharmaceutical Section. 91-97.
7. Huque MF, Dubey S, Fredd S. Establishing therapeutic equivalence with clinical endpoints. American Statistical Association 1990. Proceedings of the Biopharmaceutical Section. 46-52.
8. Lee ML, Lusher JM. The problem of therapeutic equivalence with paired qualitative data: An example from a clinical trial using haemophiliacs with an inhibitor to factor VIII. Stat Med. 1991; 10:433-441.
9. Mau J. A statistical assessment of clinical equivalence. Stat Med. 1988;7:1267-1277.
10. Mehta CR, Patel NR, Tsiatis AA. Exact significance testing to establish treatment equivalence with ordered categorical data. Biometrics. 1984; 40:819-825.
11. Rodary C, Com-Nougue C, Tournade MF. How to establish equivalence between treatments: A one-sided clinical trials in pediatric oncology. Stat Med. 1989;8:593-598.
12. Röhmel J. Der Gebrauch des Begriffes "Äquivalenz" beim Nachweis der Wirksamkeit von Arzneimitteln. In: Michaelis, J, Hommel, G, Wellek, S (Hrsg.): Europäische Perspektiven der Medizinischen Informatik, Biometrie und Epidemiologie. München: MMV Medizin Verlag; 1983:139-142.
13. Steinijans V, Hauschke D, Diletti E. Biometrische Bewertung der therapeutischen Äquivalenz. In: Blume, H (Hrsg.): Qualitätsbewertung von nicht-systemisch wirkenden Arzneimitteln. Proc. 9. ZL-Expertemreffen Frankfurt/Main: Govi-Verlag; 1992.
14. Victor N. On clinically relevant differences and shifted nullhypotheses, Meth Inf Med. 1987;26:109-116.
15. Wellek S. Methoden zum Nachweis von Äquivalenz. Stuttgart: Gustav Fischer; 1994.
16. Durrleman S, Simon R. Planning and monitoring of equivalence studies. Biometrics. 1990;46:329-336.
17. Garbe E, Röhmel J, Gundert-Remy U. Clinical and statistical issues in therapeutic equivalence trials. Eur J Clin Pharm. 1993;45:1-7.
18. Gould AL. Another view of active controlled trials. Control Clin Trials. 1991;12:474-485.
19. Makuch R, Pledger G, Hall DB, Johnson MF,H-erson J, Hsu JP. Active control equivalence studies. In: Peace, KE (Ed.): Statistical issues in drug research and development. New York: Marcel Dekker; 1990.
20. Makuch R, Johnson M. Issues in planning and interpreting active control equivalence studies. J Clin Epidemiol. 1989;42:503-511.
21. Pledger GW, Hall D. Active control trials: Do they address the efficacy issue? American Statistical Association 1990. Proceedings of the Biopharmaceutical Section. 1-10.
22. Senn S. Inherent difficulties with active control equivalence studies. Stat Med. 1993; 12:2367-2375.
23. Senn S. Falsificationism and clinical trials. Stat Med. 1992; 10:1679-1692.
24. Temple R. Difficulties in evaluating positive control trials. American Statistical Association 1983. Proceedings of the Biopharmaceutical Section. 48-54.